Trial Profile
Outcomes of sustained-release formulation of valproate and topiramate monotherapy in patients with epilepsy: a multi-centre, cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Topiramate (Primary) ; Valproic acid (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- 21 May 2012 Actual end date (15 Jun 2011) added as reported by Chinese Clinical Trial Register.
- 09 May 2012 New trial record